Stockreport

Allogene (ALLO) Inks Deal With Arbor Bio for CRISPR Technology [Yahoo! Finance]

Allogene Therapeutics, Inc.  (ALLO) 
Last allogene therapeutics, inc. earnings: 2/27 04:30 am Check Earnings Report
PDF Allogene intends to utilize Arbor's CRISPR technology with its own proprietary platform to develop next-generation allogeneic CAR T (AlloCAR T) therapies targeting auto [Read more]